rs753924410
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014915.3(ANKRD26):c.4636G>C(p.Asp1546His) variant causes a missense change. The variant allele was found at a frequency of 0.0000585 in 1,605,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014915.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151964Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000645 AC: 16AN: 247992Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134606
GnomAD4 exome AF: 0.0000585 AC: 85AN: 1453504Hom.: 0 Cov.: 31 AF XY: 0.0000581 AC XY: 42AN XY: 723170
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151964Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74250
ClinVar
Submissions by phenotype
not provided Uncertain:2Other:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Variant interpretted as Uncertain significance and reported on 11-06-2016 by Lab or GTR ID 1238. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 1546 of the ANKRD26 protein (p.Asp1546His). This variant is present in population databases (rs753924410, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ANKRD26-related conditions. ClinVar contains an entry for this variant (Variation ID: 434206). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Thrombocytopenia 2 Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.D1546H variant (also known as c.4636G>C), located in coding exon 31 of the ANKRD26 gene, results from a G to C substitution at nucleotide position 4636. The aspartic acid at codon 1546 is replaced by histidine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at